AJ WEALTH STRATEGIES, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AJ WEALTH STRATEGIES, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$204,839
-18.9%
15,2410.0%0.01%
-23.1%
Q1 2023$252,696
+89191.9%
15,2410.0%0.01%
-13.3%
Q4 2022$283
-99.9%
15,241
-4.6%
0.02%
+25.0%
Q3 2022$205,000
+83.0%
15,9710.0%0.01%
+100.0%
Q2 2022$112,000
-15.2%
15,9710.0%0.01%
-14.3%
Q1 2022$132,000
+22.2%
15,9710.0%0.01%
+40.0%
Q4 2021$108,000
+11.3%
15,971
-12.6%
0.01%0.0%
Q3 2021$97,000
-7.6%
18,2700.0%0.01%
-16.7%
Q2 2021$105,000
+25.0%
18,2700.0%0.01%0.0%
Q1 2021$84,000
+37.7%
18,2700.0%0.01%
+20.0%
Q4 2020$61,000
+13.0%
18,2700.0%0.01%0.0%
Q3 2020$54,000
-35.7%
18,2700.0%0.01%
-44.4%
Q2 2020$84,000
+20.0%
18,2700.0%0.01%0.0%
Q1 2020$70,000
+1.4%
18,2700.0%0.01%
+12.5%
Q4 2019$69,000
-33.7%
18,270
-6.3%
0.01%
-42.9%
Q3 2019$104,000
+38.7%
19,5000.0%0.01%
+27.3%
Q2 2019$75,000
-24.2%
19,5000.0%0.01%
-31.2%
Q1 2019$99,000
+167.6%
19,5000.0%0.02%
+128.6%
Q4 2018$37,00019,5000.01%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders